IIdoven
Idoven is a Madrid-based health technology company that builds an AI-powered "cardiology-as-a-service" platform for cardiovascular disease detection and precision medicine. Its CE-marked Class IIa product, Willem, automatically analyses ECGs from a wide range of devices to detect 22 cardiac patterns, serving medtech OEMs, pharma/life sciences (cardiotoxicity and risk stratification) and preventative screening programmes. Founded in 2018 out of research at Spain's CNIC, it raised a $12.9M Series A co-led by Insight Partners and Northzone in June 2022 (announced as $19.8M total with EIC Accelerator grant/equity), and counts athletes Iker Casillas and Pau Gasol among its angel backers.
SectorsHealthtech, Medical Devices, Artificial Intelligence, Digital Health, Cardiology, SaaS
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Founders
J
José María Lillo Castellano
Co-Founder & Chief Scientific Officer
M
Manuel Marina Breysse
Co-Founder & CEO (cardiologist)
Global models 5
HHeartFlow
United States · www.heartflow.com ↗
Charges per analysis for AI that turns patients' cardiac data (coronary CT) into diagnostic reports that clinicians use, much as Idoven does with ECGs.
~$900MComparable
CCleerly
United States · cleerlyhealth.com ↗
Sells AI analysis of heart scans (coronary CT) as a service to hospitals and pharma, for cardiovascular risk stratification and precision medicine.
~$280MComparable
EEko Health
United States · www.ekohealth.com ↗
Its FDA-cleared AI reads ECG and heart-sound data from devices to detect heart disease and is sold to health systems and screening programmes.
~$165MComparable
AAliveCor
United States · www.alivecor.com ↗
Its regulated AI ECG interpretation detects arrhythmias across its own and partner devices, and it also offers cardiology services to pharma and payers.
~$150MComparable
IiRhythm Technologies
United States · www.irhythmtech.com ↗
Runs ECG monitoring as a service: recordings from its wearable are analysed with deep-learning algorithms to detect cardiac arrhythmias and turned into reports for clinicians.
~$150M (pre-IPO)Comparable
In the same niche 48 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 15
Open as list →
NNorthzone
northzone.com
IInsight Partners
www.insightpartners.com
WWayra
wayra.com
AAccel
www.accel.com
EEIC Fund
eic.ec.europa.eu
I
Iker Casillas
A
Adam Chekroud
B
Brad Fluegel
D
Diego Piacentini
GGasol16 Ventures
HHambro Perks
L
Luis Sanz
R
Ron Vianu
S
Sebastian Gunningham
V
Vlad Lata
Funding rounds 4
·3 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-09-05 | Series A | — |
Northzone
+5 more
|
| 2022-06-21 | Series A | $12.9M |
Insight Partners, Northzone
+7 more
|
| 2021-05-24 | Seed | €2M incl. debt: equity and debt, the split was not disclosed |
Lead not disclosed
+3 more
|
| 2020-05-05 | Pre-seed (estimated) | — |
Lead not disclosed
+1 more
|
Not counted (3)
| 2023-07-31 | Grant | €1.5M |
No single lead
+1 more
|
| 2022-06-21 | Grant | — | European Innovation Council (EIC) Fund |
| 2021-05-24 | Public Loan | — | ENISA |
News
No coverage on record yet.